USD10
IPSC Shares
About Century TherapeuticsCentury Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
USD10
IPSC Shares
About Century TherapeuticsCentury Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$442.12M
OPEN PRICE
$2.50
LOW (1Y)
$0.3418
HIGH (1Y)
$3.04
LOW (24H)
$2.41
HIGH (24H)
$2.66
VOLUME (24H)
$4.99M
206.18%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.50 | |
1 Day | $2.42 | |
1 Week | $2.42 | |
1 Month | $2.07 | |
1 Year | $0.5837 |